During the past decade, Office of Dr. James A. Simon, MD conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 4 clinical trials were completed, i.e. on average, 57.1% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 4 clinical trials were completed. i.e. 133.3% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Office of Dr. James A. Simon, MD" are "Endometriosis" (2 trials), "Hot Flashes" (2 trials), "Vasomotor Symptoms Associated With Menopause" (2 trials), "Leiomyoma" (1 trials) and "Postmenopausal Symptoms" (1 trials). Many other conditions were trialed in "Office of Dr. James A. Simon, MD" in a lesser frequency.

Most popular intervention types in "Office of Dr. James A. Simon, MD" are "Drug" (8 trials), "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Elinzanetant (BAY3427080)" (2 trials), "Vilaprisan (BAY1002670)" (2 trials), "BAY1817080" (1 trials) and "Botulinum toxin type A" (1 trials). Other intervention names were less common.

The vast majority of trials in "Office of Dr. James A. Simon, MD" are 8 trials for "Female" genders.

Currently, there are NaN active trials in "Office of Dr. James A. Simon, MD". undefined are not yet recruiting, undefined are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Office of Dr. James A. Simon, MD, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Office of Dr. James A. Simon, MD, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".